Sagimet Biosciences Files 8-K Report
Ticker: SGMT · Form: 8-K · Filed: May 8, 2025 · CIK: 1400118
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
Sagimet Biosciences dropped an 8-K on May 8th covering ops, financials, and other events.
AI Summary
On May 8, 2025, Sagimet Biosciences Inc. filed an 8-K report detailing results of operations, other events, and financial statements. The company, formerly known as 3-V Biosciences, Inc., is incorporated in Delaware and headquartered in San Mateo, California.
Why It Matters
This filing provides an update on Sagimet Biosciences' operational and financial status, which is crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing operational and financial updates, not indicating any immediate material changes or risks.
Key Players & Entities
- Sagimet Biosciences Inc. (company) — Registrant
- 3-V Biosciences, Inc. (company) — Former company name
- May 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Mateo, California (location) — Principal executive offices
FAQ
What is the primary purpose of this Form 8-K filing for Sagimet Biosciences Inc.?
The Form 8-K filing reports on Sagimet Biosciences Inc.'s results of operations and financial condition, other events, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 8, 2025.
What is Sagimet Biosciences Inc.'s state of incorporation?
Sagimet Biosciences Inc. is incorporated in Delaware.
What is the address of Sagimet Biosciences Inc.'s principal executive offices?
The address of Sagimet Biosciences Inc.'s principal executive offices is 155 Bovet Road, Suite 303, San Mateo, California 94402.
What was Sagimet Biosciences Inc.'s former company name?
Sagimet Biosciences Inc.'s former company name was 3-V Biosciences, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Sagimet Biosciences Inc. (SGMT).